Career history of Nikhil Mehta
Former positions of Nikhil Mehta
| Companies | Position | Start | End |
|---|---|---|---|
| AVEO PHARMACEUTICALS, INC. | General Counsel | 2017-11-19 | 2019-10-07 |
| BAXALTA INC | General Counsel | 2015-03-31 | 2016-05-31 |
| MERCK & CO., INC. | General Counsel | 2009-12-31 | 2014-12-31 |
Tang Capital Management LLC
 Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | General Counsel | - | - |
Training of Nikhil Mehta
| Rutgers State University of New Jersey | Doctorate Degree |
Statistics
International
| United States | 5 |
| France | 2 |
Operational
| General Counsel | 4 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Private companies | 3 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | Finance |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Nikhil Mehta
- Experience
